The significant inhibition of AChE and BChE points to the possibility of using these compounds in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, through a mechanism of inhibition of acetylcholine-degrading enzymes. This evidence concerns the gene BCHE and neurodegenerative disease.